IGWM
ATYR

ICA Group Wealth Management’s aTyr Pharma ATYR Stock Holding History

ICA Group Wealth Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-75
Closed -$162 – 1279
2023
Q2 		$162 Buy
+75
New +$164 ﹤0.01% 1301

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ICA Group Wealth Management's ATYR Position: Q3 2023 in Review

ICA Group Wealth Management sold out of aTyr Pharma (ATYR) in Q3 2023, closing a stake of 75 shares — an estimated $162 sold.

ICA Group Wealth Management first reported a position in ATYR in Q2 2023 and held it in 1 quarter. The position peaked at $162 in Q2 2023. 40 funds tracked by Wall St. Rank hold ATYR as of Q3 2023.

  • ICA Group Wealth Management reported no remaining aTyr Pharma position as of Q3 2023 after selling out during the quarter.
  • ICA Group Wealth Management sold 75 aTyr Pharma shares in Q3 2023, an estimated $162.
  • ICA Group Wealth Management first reported a position in aTyr Pharma in Q2 2023 and held it in 1 quarter.
  • ICA Group Wealth Management's aTyr Pharma position peaked at $162 in Q2 2023.
  • 40 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2023.

Based on ICA Group Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.